Note 19 - Segment Information

9 Months Ended

Sep. 30, 2020

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

19. SEGMENT INFORMATION

The Company has determined that its continuing operations are

one

discrete segment consisting of biometric products. Geographically, North American sales accounted for approximately

95%

and

79%

of the Company's total sales for the

three

months ended

September 30, 2020

and

2019,

respectively, and were approximately

90%

and

56%

of the Company's total sales for the

nine

months ended

September 30, 2020

and

2019,

respectively.